OrganOx Ltd, a leading organ medical technology company, has announced that Health Canada has approved the OrganOx metra System for use during liver transplantation. The OrganOx metra System is currently commercially available for liver transplantation in the U.S., the U.K., and the European Union. The company plans to commercially launch the system in Canada in 2025.

The OrganOx metra System utilises normothermic machine perfusion, or NMP, to circulate oxygenated blood, medications, and nutrients to donated organs at normal body temperature and near physiological conditions. This innovative technology extends organ preservation time, allows pre-transplant clinical assessment of organ viability and can dramatically improve operational logistics for both transplant teams and patients.